Journal
Science Translational Medicine
Publication Date
5-25-2022
Volume
14
Issue
646
First Page
eabn1252
Document Type
Open Access Publication
DOI
10.1126/scitranslmed.abn1252
Rights and Permissions
Hunt AC, Case JB, Park YJ, Cao L, Wu K, Walls AC, Liu Z, Bowen JE, Yeh HW, Saini S, Helms L, Zhao YT, Hsiang TY, Starr TN, Goreshnik I, Kozodoy L, Carter L, Ravichandran R, Green LB, Matochko WL, Thomson CA, Vögeli B, Krüger A, VanBlargan LA, Chen RE, Ying B, Bailey AL, Kafai NM, Boyken SE, Ljubetič A, Edman N, Ueda G, Chow CM, Johnson M, Addetia A, Navarro MJ, Panpradist N, Gale M Jr, Freedman BS, Bloom JD, Ruohola-Baker H, Whelan SPJ, Stewart L, Diamond MS, Veesler D, Jewett MC, Baker D. Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice. Sci Transl Med. 2022 May 25;14(646):eabn1252. doi.org/10.1126/scitranslmed.abn1252 This is an open-access article distributed under the terms of the Creative Commons Attribution license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Recommended Citation
Hunt, Andrew C; Case, James Brett; Chen, Rita E; Ying, Baoling; Bailey, Adam L; Kafai, Natasha M; Diamond, Michael S; and et al, "Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice." Science Translational Medicine. 14, 646. eabn1252 (2022).
https://digitalcommons.wustl.edu/open_access_pubs/11958
multivalent supplementary materials 2.pdf (294 kB)
multivalent supplementary materials 3.zip (4416 kB)
